Advertisement

Heart Failure pp 129-137 | Cite as

Clinical Practice Guidelines in Heart Failure: State of the Art in the United States

  • Marvin A. Konstam
  • David W. Baker
Conference paper

Abstract

As we examine the speed with which treatment advances are unfurled within the medical literature, we are often lulled into directly equating a p-value below 0.05 to an improvement in the health of our patient population. In fact, no life has ever been saved or improved in quality by any p-value, however small. A significant p-value, derived from a well-designed randomized clinical trial, is merely an initial step along a lengthy road toward improved clinical outcomes. The steps along this road and the tools that permit or facilitate taking each step are listed in Table 1.

Keywords

Heart Failure Clinical Practice Guideline Disease Management Program Isosorbide Dinitrate Implantable Cardiac Defibrillator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Konstam MA, Dracup K, Baker D, Bottorff M, Brooks NH, Dacey RA, Dunbar SB, Jackson A, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Pitt B, Rose EA, Rubin LJ, Wright RF, Hadorn DC (1994) Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Agency for Health Care Policy and Research, U.S. Dept. of Health and Human Services, Rockville, MDGoogle Scholar
  2. 2.
    Packer M, Cohn JN (eds) (1999) Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83 (2A)Google Scholar
  3. 3.
    ACC/AHA Task Force on Practice Guidelines (1995) Guidelines for the evaluation and management of heart failure. Circulation 92: 2764–2784Google Scholar
  4. 3.
    ACC/AHA Task Force on Practice Guidelines (1995) Guidelines for the evaluation and management of heart failure. Circulation 92: 2764–2784Google Scholar
  5. 5.
    Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. for the US Carvedilol Heart Failure Study Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349–1355CrossRefGoogle Scholar
  6. 6.
    CIBIS II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomised trial. Lancet 353: 9–13CrossRefGoogle Scholar
  7. 7.
    Goldstein S, Hjalmarson S (1998) Metorpolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF): an update after completed randomization. Circulation Suppl I: I - 364Google Scholar
  8. 8.
    Natterson PD, Stevenson WG, Saxon LA, et al. (1995) Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 129: 564–570PubMedCrossRefGoogle Scholar
  9. 9.
    Loh E, Sutton MS, Wun CC, et al. (1997) Ventricular dysfunction predicts stroke following myocardial infarction. N Engl J Med 336: 251–257PubMedCrossRefGoogle Scholar
  10. 10.
    Dries DL, Rosenberg Y, Waclawiw M, Domanski M (1997) Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 29: 1074–1080PubMedCrossRefGoogle Scholar
  11. 11.
    Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA (1998) Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Col Cardiol 31: 749–753CrossRefGoogle Scholar
  12. 12.
    A1-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA (1998) Effect of antiplatelet agents on survival in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 31: 419–425CrossRefGoogle Scholar
  13. 13.
    Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333: 1190–1195PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2000

Authors and Affiliations

  • Marvin A. Konstam
    • 1
  • David W. Baker
    • 2
  1. 1.Department of Medicine, Division of CardiologyNew England Medical Center and Tufts University School of MedicineBostonUSA
  2. 2.Department of Medicine, Center for Health Care Research and PolicyCase Western Reserve University at Metro Health Medical CenterClevelandUSA

Personalised recommendations